Commonwealth Equity Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.5M | Sell |
70,841
-4,595
| -6% | -$2.21M | 0.04% | 389 |
|
|
2026
Q1 | $37.1M | Sell |
75,436
-6,351
| -8% | -$3.45M | 0.05% | 362 |
|
|
2025
Q4 | $47.4M | Sell |
81,787
-9,838
| -11% | -$5.56M | 0.06% | 296 |
|
|
2025
Q3 | $44.4M | Sell |
91,625
-15,692
| -15% | -$7.3M | 0.06% | 326 |
|
|
2025
Q2 | $43.5M | Sell |
107,317
-6,631
| -6% | -$2.77M | 0.06% | 326 |
|
|
2025
Q1 | $56.7M | Buy |
113,948
+4,199
| +4% | +$2.27M | 0.08% | 247 |
|
|
2024
Q4 | $57.1M | Buy |
109,749
+2,478
| +2% | +$1.36M | 0.08% | 224 |
|
|
2024
Q3 | $66.4M | Sell |
107,271
-6,118
| -5% | -$3.62M | 0.1% | 197 |
|
|
2024
Q2 | $62.7M | Buy |
113,389
+984
| +0.9% | +$564K | 0.1% | 188 |
|
|
2024
Q1 | $65.3M | Buy |
112,405
+7,620
| +7% | +$4.28M | 0.11% | 174 |
|
|
2023
Q4 | $55.6M | Buy |
104,785
+5,082
| +5% | +$2.46M | 0.1% | 192 |
|
|
2023
Q3 | $50.5M | Buy |
99,703
+835
| +0.8% | +$445K | 0.1% | 182 |
|
|
2023
Q2 | $51.6M | Buy |
98,868
+11,131
| +13% | +$6.01M | 0.1% | 185 |
|
|
2023
Q1 | $50.6M | Sell |
87,737
-3,616
| -4% | -$2.04M | 0.11% | 177 |
|
|
2022
Q4 | $50.3M | Buy |
91,353
+1,733
| +2% | +$918K | 0.12% | 165 |
|
|
2022
Q3 | $45.5M | Buy |
89,620
+645
| +0.7% | +$361K | 0.12% | 165 |
|
|
2022
Q2 | $48.3M | Sell |
88,975
-401
| -0.4% | -$221K | 0.13% | 161 |
|
|
2022
Q1 | $52.8M | Buy |
89,376
+1,473
| +2% | +$846K | 0.12% | 165 |
|
|
2021
Q4 | $58.7M | Sell |
87,903
-842
| -0.9% | -$526K | 0.13% | 154 |
|
|
2021
Q3 | $50.7M | Buy |
88,745
+3,048
| +4% | +$1.67M | 0.13% | 161 |
|
|
2021
Q2 | $43.2M | Buy |
85,697
+7,436
| +10% | +$3.51M | 0.11% | 186 |
|
|
2021
Q1 | $35.7M | Sell |
78,261
-9,203
| -11% | -$4.39M | 0.1% | 209 |
|
|
2020
Q4 | $40.7M | Buy |
87,464
+7,440
| +9% | +$3.49M | 0.12% | 174 |
|
|
2020
Q3 | $35.3M | Buy |
80,024
+499
| +0.6% | +$206K | 0.12% | 178 |
|
|
2020
Q2 | $28.8M | Buy |
79,525
+10,263
| +15% | +$3.44M | 0.11% | 190 |
|
|
2020
Q1 | $19.6M | Buy |
69,262
+1,562
| +2% | +$493K | 0.09% | 214 |
|
|
2019
Q4 | $22M | Buy |
67,700
+5,125
| +8% | +$1.55M | 0.08% | 225 |
|
|
2019
Q3 | $18.2M | Buy |
62,575
+3,065
| +5% | +$878K | 0.08% | 249 |
|
|
2019
Q2 | $17.5M | Buy |
59,510
+5,461
| +10% | +$1.5M | 0.08% | 250 |
|
|
2019
Q1 | $14.8M | Buy |
54,049
+4,396
| +9% | +$1.09M | 0.07% | 278 |
|
|
2018
Q4 | $11.1M | Buy |
49,653
+1,802
| +4% | +$423K | 0.06% | 302 |
|
|
2018
Q3 | $11.7M | Buy |
47,851
+6,516
| +16% | +$1.5M | 0.06% | 300 |
|
|
2018
Q2 | $8.56M | Buy |
41,335
+2,882
| +7% | +$612K | 0.04% | 352 |
|
|
2018
Q1 | $7.94M | Sell |
38,453
-1,723
| -4% | -$362K | 0.04% | 348 |
|
|
2017
Q4 | $7.63M | Buy |
40,176
+4,137
| +11% | +$793K | 0.04% | 363 |
|
|
2017
Q3 | $6.82M | Buy |
36,039
+1,576
| +5% | +$285K | 0.04% | 362 |
|
|
2017
Q2 | $6.01M | Sell |
34,463
-3,976
| -10% | -$668K | 0.04% | 376 |
|
|
2017
Q1 | $5.9M | Buy |
38,439
+2,620
| +7% | +$400K | 0.04% | 373 |
|
|
2016
Q4 | $5.05M | Buy |
35,819
+3,891
| +12% | +$574K | 0.04% | 380 |
|
|
2016
Q3 | $5.08M | Buy |
31,928
+4,307
| +16% | +$664K | 0.04% | 359 |
|
|
2016
Q2 | $4.08M | Buy |
27,621
+1,132
| +4% | +$167K | 0.03% | 416 |
|
|
2016
Q1 | $3.75M | Buy |
26,489
+1,892
| +8% | +$254K | 0.03% | 430 |
|
|
2015
Q4 | $3.49M | Sell |
24,597
-975
| -4% | -$130K | 0.03% | 438 |
|
|
2015
Q3 | $3.13M | Buy |
25,572
+1,088
| +4% | +$142K | 0.03% | 450 |
|
|
2015
Q2 | $3.18M | Buy |
24,484
+333
| +1% | +$43.4K | 0.03% | 464 |
|
|
2015
Q1 | $3.24M | Buy |
24,151
+1,205
| +5% | +$155K | 0.03% | 447 |
|
|
2014
Q4 | $2.88M | Buy |
22,946
+6
| +0% | +$730 | 0.03% | 449 |
|
|
2014
Q3 | $2.79M | Sell |
22,940
-5,013
| -18% | -$610K | 0.03% | 440 |
|
|
2014
Q2 | $3.3M | Buy |
27,953
+953
| +4% | +$112K | 0.04% | 383 |
|
|
2014
Q1 | $3.25M | Buy |
27,000
+2,708
| +11% | +$322K | 0.04% | 353 |
|
|
2013
Q4 | $2.71M | Buy |
24,292
+220
| +0.9% | +$21.9K | 0.04% | 385 |
|
|
2013
Q3 | $2.22M | Buy |
24,072
+3,562
| +17% | +$322K | 0.04% | 419 |
|
|
2013
Q2 | $1.74M | Buy |
+20,510
| New | +$1.71M | 0.03% | 462 |
|
Other funds holding TMO
Commonwealth Equity Services's TMO Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Thermo Fisher Scientific (TMO) stake by 6.1% in Q2 2026, selling an estimated $2.21M and leaving 70,841 shares worth $35.5M. The position accounts for 0.04% of the portfolio, ranked #389.
Commonwealth Equity Services first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $66.4M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Commonwealth Equity Services held 70,841 shares of Thermo Fisher Scientific worth $35.5M as of Q2 2026.
- Commonwealth Equity Services sold 4,595 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.21M.
- Thermo Fisher Scientific made up 0.04% of Commonwealth Equity Services's portfolio in Q2 2026, its #389 holding.
- Commonwealth Equity Services first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Commonwealth Equity Services's Thermo Fisher Scientific position peaked at $66.4M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.